Sort
23,748 grants matching “melanoma”
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
$648,555David A. Hafler · Yale University · R01 · FY2024 · CA
Peripheral immune surveillance and long-lived barrier immunity through T cell DC cross-talk
$648,534Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R56 · FY2021 · AR
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS
$648,075Pavithra Viswanath · University Of California, San Francisco · R01 · FY2021 · CA
Regulatory T cells in cancer therapy
$647,392Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Regulatory T cells in cancer therapy
$647,349Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Melanoma Resistance Evolution Atlas (MREA) for identifying combinatorial targets to prevent and reverse MAPKi resistance
$647,072Roger S Lo · University Of California Los Angeles · R01 · FY2025 · CA
Small-molecule degraders of STAT5
$646,994Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Small-molecule degraders of STAT5
$646,849Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Validating and Characterizing a New Melanoma Therapeutic Target
$646,803Sara A Courtneidge · Oregon Health & Science University · R01 · FY2017 · CA
IN VIVO IMAGING OF SINGLE CIRCULATING CELLS
$646,722Lihong Wang · Washington University · R01 · FY2015 · CA
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
$646,659Tyler J. Curiel · Dartmouth-Hitchcock Clinic · R01 · FY2022 · CA
Cancer Resistant Mice
$646,549Bruce A Beutler · Ut Southwestern Medical Center · R01 · FY2024 · CA
IMMUNOTHERAPY OF MELANOMA: TARGETING HELIOS IN THE TUMOR MICROENVIRONMENT FOR EFFECTOR CELL CONVERSION
$646,313Dana-Farber Cancer Institute, Inc. · · FY2017 · Department of the Army
Plasma-based therapies for bone infection: A tripartite USA/Northern Ireland/Republic of Ireland consortium
$646,298Theresa A Freeman · Thomas Jefferson University · R01 · FY2024 · AR
Determining the clinical impact of gene expression testing in localized prostate cancer
$646,294Todd M. Morgan · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$646,146Robert H Vonderheide · University Of Pennsylvania · P01 · FY2021 · CA
Targeting RAS in Pediatric Cancer
$646,143Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Innate Immune Control of TB and HIV
$646,050Anne Goldfeld · Boston Children'S Hospital · R56 · FY2021 · AI
A Multi-Level Investigation of US Indoor Tanning PolicyEnactment, Implementation, Compliance, Impact, and Economics
$645,949Carolyn J. Heckman · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
The role of IWS1 in development and tumorigenesis
$645,852Philip N Tsichlis · Ohio State University · R01 · FY2018 · CA
Designer extracellular vesicles for cancer therapy
$645,726Xiaowei Xu · University Of Pennsylvania · R01 · FY2025 · CA
Retinoic Acid Induced Lymphangiogenesis for Post-Surgical Lymphedema
$645,721Alex K. Wong · Rutgers Biomedical And Health Sciences · R01 · FY2024 · HL
An innovative, curriculum-based integrated sun exposure behavior intervention for
$645,278Myles G Cockburn · University Of Southern California · R01 · FY2013 · CA
Research Project 2 - Targeting Melanoma Tumor Survival and Apoptotic Machinery
$645,228Michael Davies · Wistar Institute · U54 · FY2017 · CA
Enhanced Development of the Xiphophorus Model System
$645,034Yuan Lu · Texas State University · R24 · FY2019 · OD